Tipo : |
periódico |
Enlace : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4750 |
|
Los equipos de investigación : |
Sydney - National Institute of Complementary Medicine, Western Sydney University |
Autores : |
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
Título : |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. |
número : |
Int J Pharm Compound ;24,1:77-82 2020 |
|
Nivel de evidencia : |
|
La estabilidad física : |
|
Estabilidad química : |
|
otros métodos : |
|
Comentarios : |
|
Lista de la molécula
Metronidazole
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|